SCHEMBL3594252

SCHEMBL3594252

CN(C)c1ncc([N+](=O)[O-])cc1C(F)(F)F

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 1.00
▸ HTT P42858 3/20 0.38
▸ GAA P10253 1/20 0.38
▸ POLB P06746 1/20 0.37
▸ IDO1 P14902 1/20 0.37
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ L3MBTL1 Q9Y468 3/20 0.37
▸ GALR3 O60755 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ MAPT P10636 2/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ PDE7A Q13946 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ CXCR5 P32302 1/20 0.36
▸ APLNR P35414 1/20 0.36
▸ CCR6 P51684 1/20 0.36
▸ PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14358402 0.80 ALDH1A1 (0.67) ALDH1A1HTTGAAIDO1MEN1
SCHEMBL19823971 0.80 ALDH1A1 (0.66) ALDH1A1HTTGAAPOLBMEN1
SCHEMBL29455943 0.79 ALDH1A1 (0.65) ALDH1A1HTTPOLBIDO1MEN1
SCHEMBL20569282 0.79 ALDH1A1 (0.65) ALDH1A1HTTPOLBIDO1MEN1
SCHEMBL19817179 0.78 ALDH1A1 (0.63) ALDH1A1HTTGAAPOLBMEN1
SCHEMBL19817181 0.78 ALDH1A1 (0.63) ALDH1A1HTTGAAPOLBMEN1
SCHEMBL23608393 0.77 ALDH1A1 (0.63) ALDH1A1HTTGAAPOLBIDO1
SCHEMBL26878892 0.77 ALDH1A1 (0.62) ALDH1A1HTTGAAPOLBIDO1
SCHEMBL10346382 0.77 ALDH1A1 (0.62) ALDH1A1HTTGAAPOLBMEN1
SCHEMBL1100036 0.77 ALDH1A1 (0.62) ALDH1A1HTTGAAIDO1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1632477-B1 BENZAMIDE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC (JP) 2017-03-01 — — EP disclosed
EP-2736882-A1 SUBSTITUTED HETEROCYCLIC AZA DERIVATIVES Grünenthal GmbH (DE) 2014-06-04 — — EP disclosed
EP-2736900-A1 SUBSTITUTED HETEROAROMATIC PYRAZOLE-CONTAINING CARBOXAMIDE AND UREA DERIVATIVES AS VANILLOID RECEPTOR LIGANDS Grünenthal GmbH (DE) 2014-06-04 — — EP disclosed
CN-103842357-A Substituted heteroaromatic pyrazole-containing carboxamide and urea compounds as vanilloid receptor ligands GRUENENTHAL GMBH 2014-06-04 — — CN disclosed
US-20130029961-A1 Substituted Heterocyclic Aza Compounds GRUENENTHAL GMBH (DE) 2013-01-31 — — US disclosed
WO-2013013817-A1 SUBSTITUTED HETEROCYCLIC AZA DERIVATIVES Grünenthal GmbH (DE) 2013-01-31 — — WO disclosed
WO-2013013817-A1 SUBSTITUTED HETEROCYCLIC AZA DERIVATIVES Grünenthal GmbH (DE) 2013-01-31 — — WO disclosed
WO-2013013815-A1 SUBSTITUTED HETEROAROMATIC PYRAZOLE-CONTAINING CARBOXAMIDE AND UREA DERIVATIVES AS VANILLOID RECEPTOR LIGANDS Grünenthal GmbH (DE) 2013-01-31 — — WO disclosed
WO-2013013815-A1 SUBSTITUTED HETEROAROMATIC PYRAZOLE-CONTAINING CARBOXAMIDE AND UREA DERIVATIVES AS VANILLOID RECEPTOR LIGANDS Grünenthal GmbH (DE) 2013-01-31 — — WO disclosed
US-20130029961-A1 Substituted Heterocyclic Aza Compounds GRUENENTHAL GMBH (DE) 2013-01-31 — — US disclosed
US-20130029962-A1 Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands GRUENENTHAL GMBH (DE) 2013-01-31 — — US disclosed
US-20130029962-A1 Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands GRUENENTHAL GMBH (DE) 2013-01-31 — — US disclosed
US-7855198-B2 Benzamide derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2010-12-21 — — US disclosed
CN-100562513-C Benzamide derivatives or its salt ASTELLAS PHARMA INC (JP) 2009-11-25 — — CN disclosed
US-20090270365-A1 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics ASTELLAS PHARMA INC. (JP) 2009-10-29 — — US disclosed
US-7585878-B2 Benzamide derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2009-09-08 — — US disclosed
US-7585878-B2 Benzamide derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2009-09-08 — — US disclosed
US-20070167444-A1 Benzamide derivative or salt thereof ASTELLAS PHARMA INC. 2007-07-19 — — US disclosed
CN-1805923-A Benzamide derivative or salt thereof ASTELLAS PHARMA INC (JP) 2006-07-19 — — CN disclosed
EP-1632477-A1 BENZAMIDE DERIVATIVE OR SALT THEREOF Astellas Pharma Inc. (JP) 2006-03-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270365-A1 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics TRPV1, TRPV2, TRPV3 ALDH1A1 1223/4885HTT 2023/4885GAA 4357/4885
US-20070167444-A1 Benzamide derivative or salt thereof TRPV1, BDKRB1, BDKRB2 ALDH1A1 1426/4885HTT 1422/4885GAA 3382/4885
US-20130029961-A1 Substituted Heterocyclic Aza Compounds TRPV1, GPR17, TRPV2 ALDH1A1 1529/4885HTT 2298/4885GAA 2046/4885
US-20130029962-A1 Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands TRPV1, GPR17, TRPV3 ALDH1A1 3441/4885HTT 2794/4885GAA 2687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback